Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.

Biotechnology

Education

Shoreline Biosciences

Shoreline Biosciences' headquarters in San Diego, CA, United States

Vanessa Jacoby

Scott Forrest

Lyuda Hillman

Cassandra Cook

Marios Fotiadis

Travis S. Young

Silke Paust

Scott Antonia

Judith Shizuru

Frank Yu

Christopher Fuglesang

Steven Holtzman

The Scientific Research team at Shoreline Biosciences employs advanced iPSC differentiation methods and genetic programming techniques to enhance the IL-15/CISH pathway, aiming to improve the metabolic fitness, persistence, and anti-cancer activity of engineered NK cells. This multidisciplinary team of scientists and engineers focuses on pioneering research and development to advance Shoreline's cell therapy technology platform.

Scientific Research

The Leadership Team at Shoreline Biosciences drives the strategic vision and operational direction of the company, leveraging their extensive expertise in cell therapy and biotechnology. Comprising key executives such as the CEO, CFO, and Chief Scientific Officer, the team collaborates to advance innovative iPSC differentiation methods, oversee project management, and forge strategic partnerships, all aimed at enhancing the effectiveness of engineered NK cells in combating cancer.

Leadership Team

The Advisory Team at Shoreline Biosciences provides strategic guidance and expertise to enhance the development and implementation of the company's proprietary cell therapy technology. Comprised of seasoned professionals, including the co-founder and chair of the Scientific Advisory Board (SAB), the team advises on scientific, clinical, and commercial aspects to optimize the metabolic fitness and anti-cancer efficacy of engineered NK Cells.

Advisory Team

The Finance and Accounting team at Shoreline Biosciences is responsible for managing the company's financial health and ensuring accurate financial reporting. This includes budgeting, financial planning and analysis, managing accounts payable, and regulatory compliance, all to support the development and expansion of Shoreline's innovative cell therapy technologies.

Finance and Accounting

The Research and Development team at Shoreline Biosciences focuses on advancing the company's cell therapy technology platform. Leveraging deep expertise in iPSC differentiation and genetic programming of the IL-15/CISH pathway, the team works to enhance the metabolic fitness and persistence of engineered NK Cells to improve their anti-cancer activity.

Shoreline Biosciences

Org chart

Board & advisors

Teams

Scientific Research

Leadership Team

Advisory Team

Finance and Accounting

Research and Development

Offices

Shoreline Biosciences

Org chart

Board & advisors

Teams

Scientific Research

Leadership Team

Advisory Team

Finance and Accounting

Research and Development

Offices

Related companies